论文部分内容阅读
目的观察参芎葡萄糖注射液(参芎)联合替米沙坦治疗早期糖尿病肾病(DN)临床疗效。方法将60例早期DN患者随机分为治疗组30例和对照组30例,2组均采用胰岛素控制血糖,血糖水平控制良好。同时积极控制血压,药物均选用替米沙坦。治疗组在以上治疗的基础上联合每日静脉滴注参芎200 ml。结果 2组患者尿α1微球蛋白均下降,以上指标改善治疗组优于对照组。结论参芎联合替米沙坦对早期DN的治疗效果良好。
Objective To observe the clinical efficacy of Shenxiong and dextrose injection (Shenxiong) combined with telmisartan in the treatment of early diabetic nephropathy (DN). Methods Sixty patients with early stage DN were randomly divided into treatment group (n = 30) and control group (n = 30). Both groups adopted insulin to control blood glucose and blood sugar level was well controlled. At the same time actively control blood pressure, drug use telmisartan. Treatment group in the above treatment based on the combination of daily intravenous infusion of rhizome of 300 ml. Results Urine α1 microglobulin in both groups decreased, the above indicators improve the treatment group than the control group. Conclusion Shenxiong combined with telmisartan treatment of early DN good results.